{
    "nctId": "NCT02056067",
    "briefTitle": "Hormones and Physical Exercise (HOPE) Study",
    "officialTitle": "Hormones and Physical Exercise (HOPE) Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Arthralgia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 121,
    "primaryOutcomeMeasure": "Change from Baseline in Arthralgia Severity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women (defined as the surgical or natural absence of menstrual cycles for at least 1 year prior to breast cancer diagnosis).\n* 75 years or younger\n* AJCC Stages I-IIIC Breast Cancer\n* Taking an AI for at least 2 months\n* Currently experiencing at least mild arthralgia (= or \\> 3 on the BPI) associated with AI use\n* Physically able to exercise and physician consent to start an exercise program\n* Sedentary activity pattern (\\< 90 mins/week of moderate-to-vigorous intensity sports activity) within the past year and low fitness level\n* No more than one strength training session per week within the past year\n* Agrees to be randomly assigned to either exercise or attention control\n* Gives informed consent to participate in all study activities\n* Able to come for baseline, 6-, and 12-month clinic visits and strength training sessions (6-month intervention study - able to come for baseline, 6-month clinic visits and strength training sessions).\n* Mentally competent\n\nExclusion Criteria:\n\n* Lymphedema with self reported 'flare up' in the past 4 months",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}